Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
propofol (diprivan) (1 trial)
sevoflurane (ultane) (1 trial)
enzalutamide (xtandi) (1 trial)
Breast Neoplasms (Phase 4)
Colonic Neoplasms (Phase 4)
Coronavirus Infections (Phase 2)
Neoplasms (Phase 4)
Rectal Neoplasms (Phase 4)
Severe Acute Respiratory Syndrome (Phase 2)
Trials (2 total)
Trial APIs (3 total)